Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06591429 · ClinicalTrials.gov registry record
Smoldering Inflammation in MS
A clinical trial of Multiple Sclerosis, sponsored by Washington University School of Medicine.
- Recruiting
- Registry status
- 25
- Enrollment target
- 1
- Study location
NCT06591429 is a study of Multiple Sclerosis that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 25 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06591429, a study of Multiple Sclerosis, is actively recruiting participants, sponsored by Washington University School of Medicine.
- RECRUITING
- Registry status
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this observational study is to learn about inflammation in those with relapsing remitting Multiple Sclerosis (MS). The main questions it aims to answer are: * How does abnormal neural inflammation compare to cellular and molecular inflammation in MS? * Once treated, why does abnormal inflammation persist?
Conditions Studied
Interventions
- RADIATION Radiotracer [11C]-CS1P1
- RADIATION Radiotracer [11C]-DPA-713
- DRUG anti-CD20 MS treatment
- RADIATION Radiotracer [12F]-FDG
Study Locations (1)
Missouri
- Barnes Jewish Center for Clinical Imaging Research - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2024-06-19 |
| Est. Completion | 2027-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06591429
The ClinicalTrials.gov registry entry for NCT06591429 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (96% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 4 interventions - of which Radiotracer [11C]-CS1P1 is the first listed.
NCT06591429 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT06591429 about?
NCT06591429 is a clinical study titled "Smoldering Inflammation in MS". The goal of this observational study is to learn about inflammation in those with relapsing remitting Multiple Sclerosis (MS). The main questions it aims to answer are: * How does abnormal neural inflammation compare to cellular and molecular inflammation in MS? * Once treated, why does abnormal in...
What is the current status of trial NCT06591429?
This trial is currently recruiting. The enrollment target is 25 participants. The study started on 2024-06-19. Estimated completion is 2027-06-30.
What conditions does trial NCT06591429 study?
This clinical trial studies the following conditions: Multiple Sclerosis.
What interventions are being tested in trial NCT06591429?
The interventions under investigation include: Radiotracer [11C]-CS1P1 (RADIATION), Radiotracer [11C]-DPA-713 (RADIATION), anti-CD20 MS treatment (DRUG), Radiotracer [12F]-FDG (RADIATION).
Who is sponsoring clinical trial NCT06591429?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06591429 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
Prepare the Mind: Can Coaching in Goal-directed Behaviour Increase the Success of Cognitive Rehabilitation in People With MS?
RECRUITING · NA
-
Incremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple Sclerosis
RECRUITING · NA
-
Vancomycin Study in Multiple Sclerosis (MS)
RECRUITING · Phase 1
-
IConquerMS™ - a Patient-Powered Research Network for Multiple Sclerosis
RECRUITING
-
Prospective Investigation of Multiple Sclerosis in the Three Rivers Region
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.